Skip to main content

Table 1 Patients' main characteristics

From: Nomegestrol acetate versus combined oral contraceptive as rapid endometrial preparation for operative hysteroscopy: a prospective randomised pilot study

 

Group A (n = 21), NOMAC

Group B (n = 21), EE/GSD

P value

Age (median, SD; years)

35 ± 6

37 ± 7

0.35

BMI (median, SD; kg/m2)

22 ± 2

21 ± 3

0.22

Parity (median, range; number)

1 (0–2)

1 (0–2)

0.8

  1. NOMAC 5 mg nomegestrol acetate, EE/GSD 20 μg ethinyl estradiol/75 mg gestodene, BMI body mass index
Back to article page